Commentary

The evidence about long-term benzodiazepine use presents a confounding paradox. This commentary proposes a set of prescribing guidelines for clinicians.

Randall T. Espinoza, MD, and Aaron Kaufman, MD, discuss a study by Trevisan et al and reflect on lessons learned during the pandemic about detecting and managing delirium.

Rachel Vanderkruik, PhD, MSc, discusses Huh and colleagues’ study of online nurse-delivered group CBT for postpartum depression, highlighting 4 key aspects that make the intervention particularly exciting.

Although the administration intervals of long-acting injectable antipsychotics are a starting point for scheduling follow-ups, frequency of prescriber contact should be based on individual risk factors and real-world constraints.

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.

This article provides an overview of emerging therapies poised to transform the treatment paradigm for patients with living with schizophrenia.